Announcement on Obtaining Drug Registration Certificate by the Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate by the Subsidiary
Filed with SSE · · 3 pages · Chinese
Release
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Jiuzhou Pharmaceutical
- Announcement on Initially Repurchasing Shares through Call Auction and Progress in Repurchased Shares Reaching 1% of Total Share Capital
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on the Company's Receipt of the Notice of Approval for Marketing Application of Chemical APIs
Later from Zhejiang Jiuzhou Pharmaceutical
- Announcement on Progress in Wholly-owned Subsidiary Participating in Investment to Establish Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)
- Announcement on Closing Some Investment Projects Financed by Raised Funds and Using Residual Raised Funds to Permanently Supplement Current Capital
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Implementation of Canceling Partial Repurchased Shares
- Announcement on Completion of Industrial and Commercial Change Registration
Follow Zhejiang Jiuzhou Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Jiuzhou Pharmaceutical